Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer

Zheng Wu, Andrew Gabrielson, Jimmy J. Hwang, Michael J. Pishvaian, Louis M. Weiner, Tingting Zhuang, Lisa Ley, John L. Marshall, Aiwu Ruth He

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences